Company / Net Income
Vaxcyte, Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$766.6M
FY2025
5-year range
-$766.6M / -$100.1M
FY2021-FY2025
Trend
-65.2%
vs FY2024
Sector context
#206 of 216
Health Care
What the data says
Among 216 Health Care companies, Vaxcyte, Inc. is in the bottom 5% for net income. Net Income has declined for 7 consecutive years, from -$29M in FY2018 to -$767M in FY2025.
Based on SEC 10-K filings.
-$767M in FY2025.
Declined from -$402M to -$767M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 216This company -$766.6M Sector average $454.3M
▼
-268.7% below sector average
Key checks
Key Insights
- Vaxcyte, Inc.'s net income has declined for 7 consecutive years.
- In FY2025, net income decreased 65.2% year-over-year.
- Ranks #206 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$766.6M | -65.2% |
| FY2024 | -$463.9M | -15.3% |
| FY2023 | -$402.3M | -80.0% |
| FY2022 | -$223.5M | -123.3% |
| FY2021 | -$100.1M | -12.2% |
| FY2020 | -$89.2M | -77.5% |
| FY2019 | -$50.3M | -70.5% |
| FY2018 | -$29.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026